Early Topical Treatment For Diabetic Retinopathy May Be Possible, Research Suggests.

“Early topical treatment for diabetic retinopathy may be possible in the future, at least for a subset of diabetes patients,” according to the results of a trial presented at the European Consortium for the Early Treatment of Diabetic Retinopathy. Researchers “compared the effects of twice-daily eyedrops containing the neuroprotective agents somatostatin or brimonidine against placebo drops for arresting neurodegeneration and for effects on a variety of retinal and visual outcomes.” https://login.medscape.com/login/sso/getlogin?urlCache=aHR0cDovL3d3dy5tZWRzY2FwZS5jb20vdmlld2FydGljbGUvODg2Mjc1&ac=401